Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population

Journal of Nephropathology

Volumn 2, Issue 4, 2013, Pages 241-248

  Ardalan, Mohammad Reza ^a,b   Ghafari, Ali ^c   Hamzavi, Fatemeh ^a,b   Nasri, Hamid ^d   Baradaran, Behrooz ^a   Majidi, Jafar ^a   Nikbin, Behrooz ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti phospholipase A2 antibodies nephrotic syndrome; Anti phospholipase A2 receptor antibodies; End stage renal disease; Idiopathic membranous nephropathy

Indexed keywords

EID: 84881177076     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.12860/JNP.2013.38     Document Type: Article

References (19)

1. Beck LH Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009; 361:11–21.
2. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002; 346:2053-60.
3. Qin W, Beck LH Jr, Zeng C, et al.Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy. J Am Soc Nephrol.2011;22: 1137-1143.
4. Hofstra JM, Beck LH, Jr., Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol.2011;6:1286-91.
5. Debiec H, Martin L, Jouanneau C et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy.Am JTransplant.2011;11:2144-52.
6. Hoxha E, Harendza S, Zahner G et al. An immunofluorescence test for phospholipase-A2 -receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.Nephrol Dial Transplant.2011;26: 2526-2532.
7. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochimica et Biophysica Acta.2006;1761;11:1246-59.
8. Kini RM. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon. 2003;42: 827-840.
9. Beck LH Jr, Fervenza FC, Beck DM, et al.Rituximab-induced depletion of anti-PLA2R autoantibodies pre dicts response in membranous nephropathy. J Am Soc Nephrol.2011;22; 1543-1550.
10. Polanco N, Gutierrez E, Covarsi A et al.Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy. J Am Soc Nephrol.2010;21:697-704.
11. Cravedi P, Ruggenenti R, Remuzzi G. Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy. J Am Soc Nephrol.2011;22:1391-1402.
12. Debiec H, Ronco P. Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol.2011;7:496-8.
13. Debiec H, Ronco P. PLA R autoantibodiesand PLA R glomerular deposits in membranous nephropathy. N. Engl. J. Med.2011:364,689-690.
14. Cybulsky AV, Quigg RJ, Salant DJ. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol. 2005; 289(4):F660-71.
15. Murtas C, Ravani P, Ghiggeri GM. New insights into membranous glomerulonephritis: from bench to bedside. Nephrol Dial Transplant. 2011;26(8):2428-30.
16. Hofstra JM, Debiec H, Short CD et al. Antiphospholipase A Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy. J Am Soc Nephrol.2012;23:1735-1743.
17. Stanescu HC, Arcos-Burgos M, Medlar A et al. Risk HLA-DQA1 and PLA R1 alleles in idiopathic membranous nephropathy. N. Engl. J. Med. 2011;364,616-626.
18. Granata F, Petraroli A, Boilard E et al.Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the Mtype receptor. J Immunol. 2005;174(1):464-74.
19. Ardalan MR.Triggers, Bullets and Targets, Puzzle of Membranous Nephropathy. Nephro-Urology Monthly. 2012; 4:599-602.